Study on the Incidence of Perioperative Hypothermia at the Surgical Area of Parc Tauli Hospital Universitari, Sabadell
NCT ID: NCT03961620
Last Updated: 2022-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
101 participants
OBSERVATIONAL
2019-07-09
2022-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Convective Prewarming System in Prevention of Perioperative Hypothermia
NCT01502163
Effectiveness of Spot-on ™ to Prevent Inadvertent Perioperative Hypothermia and Their Consecuences
NCT02511080
Comparison of Electric Heating Pad Versus Forced-air Warming to Prevent Inadvertent Perioperative Hypothermia
NCT04410068
Intraoperative Body Core Temperature Monitoring: Oesophageal Probe vs Heated Controlled Servo Sensor
NCT03820232
Prevention of Perioperative Hypothermia in Patients Submitted to Transurethral Resection
NCT03630887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the patient admission area and surgical preparation, associated investigators will inform to candidates and relatives about the project giving the informed form to be signed.
Patient inclusion will include a pilot phase (four to five patients) to teach collaborators regarding the correct placement of cutaneous sensor, data lecture and registration to the database. Along with the maintenance department of the hospital, we also assess the correct installation and function of temperature and humidity sensors at the OR (Mini-datalogger 174H, Instrumentos Testo, S.A. Cabrils, Barcelona). OR temperature and the degree of humidity will be measured at the specific time points stated at the paragraph of the measurements.
Body temperature (BT) measurements will be performed at the UPQ, anesthesia preparation room, OR and URPA in those specifically stated time points (Annex 2 and Figure 1).
Because the investigators want to perform a pragmatic study, patients will receive conventional normothermia preventive measures following the approved local guidelines from the Anesthesiology Department.
Measurement and data entry Body temperature (BT) Patient's BT will be assessed with the SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit.
Non-invasive digital BT system monitorization SpotOn, includes a sensor that by adhering to the lateral side of supra-ocular region, allows for continued registration of BT for the overall surgical process.
Number of times and sites of BT registration Staff devoted to assess BT measurements. Staff from 3M, will advise nurses, anesthesiologists and investigators regarding SpotOn specifications and management at the beginning of the study
Because OR temperature and degree of humidity may have some influence on patient's BT and thermic comfort both patients and OR staff, OR temperature and humidity will be registered at the beginning and at the end of surgical procedure. Also, the protocol will take in to the account weather conditions registered at the MeteoCat and will be included at the data base regularly. Also, staff from Maintenance of Hospital Facilities and Equipment, will set up and store data from the OR temperature and humidity sensors (Mini-datalogger 174H, Instrumentos Testo, S.A. Cabrils, Barcelona).
Data about measures addressed to sustain perioperative normothermia will also be recorded (see Annex 4)
At the end of surgical procedure the investigators will ask patients and OR staff for running a visual analogic scale punctuation (1 to 10) regarding the perceived thermal comfort (see Annex 5)
Length of the study and period of patients recruitment. Because the specific nature of this prospective observational and pragmatic study, the rate of patients recruitment will be assessed frequently to accommodate both optimal patient accrual and fair and adequate entry data. The approximate time for total patients inclusion will be of one year.
Sample size The main objective of the study TAULI-PREVINQ-WARM is to assess the rate of perioperative hypothermia (\<36ªC) at some point during the surgical process in patients operated on for a major surgical procedure at the Parc Tauli, Hospital Universitari, Sabadell. Then, sample size has been calculated taking in to the account that roughly 50% of patients will have some kind of hypothermia with 10% of variability of 95% CI. Assuming a10% of repository additional patients, 110 patients will be included overall.
Assessment of data results and statistical analysis. The TAULI-PREVINQ-WARM is a pragmatic study that wants to assess body temperature in surgical patients under regular clinical conditions. We will perform a descriptive analysis of data by depicting mainly frequency distribution analysis of the qualitative main variable, HypoTer. The proposed sample size will allow also for assessing the rate HypoTer at each different surgical areas where patients are admitted. Also, repeated measures will be compared among different surgical procedures at the OR taking in to consideration the body surface area under regular preventive normothermia measures, following the general lineal model. Univariate two-sided analysis will be perform for all comparisons and parametric or non-parametric analysis will be performed accordingly. Multivariate analysis might eventually be performed depending of the rate of events.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit.
Patients submitted to major surgical procedure will be assessed for core body temperature by employing SpotOn sensor device, before, during and after surgical procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients submitted to major surgical procedures at the main OR facilities (or at the ambulatory surgery building for ophthalmologic procedures) under general or neuraxial anesthesia from surgical specialties
* Patients (parents or legal guardians regarding pediatric patients) that have signed informed consent form.
Exclusion Criteria
* Patients submitted to any surgical procedure requiring draping or sterile isolation of the frontal part of head, precluding intraoperative assessment of SpotOn sensor.
* Patients (parents or legal guardians regarding pediatric patients) that have not signed informed consent form.
* Patients that by the time of the hospital admission present a relevant inflammatory or infectious process at the skin of frontal part of the head
* Patients diagnosed with psychiatric disease relevant enough to avoid adequate staff-patients communication for this specific study
8 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
3M
INDUSTRY
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xavier Guirao
Coordinator of Endocrine, Head and Neck Surgery Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xavier Guirao, MD
Role: PRINCIPAL_INVESTIGATOR
Parc Tauli Hospital Universitari, Sabadell
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parc Tauli Hospital Universitari
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/630
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.